Belani et al. (150) examined granulosa cells from patients with PCOS and revealed that swertiamarin could elevate estradiol levels in the conditioned medium of insulin-resistant PCOS individuals, offering potential benefits for this patient population. The gene discussed is INS; the disease is polycystic ovary syndrome.